A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations

Federico Bertoglio, Viola Fühner, Maximilian Ruschig, +38

Cell Reports

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface

Federico Bertoglio, Doris Meier, Nora Langreder, +33

Nature Communications

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Sylvia Rothenberger, Daniel L. Hurdiss, Marcel Walser, +65

Nature Biotechnology

Attenuation of a very virulent Marek's disease herpesvirus (MDV) by codon pair bias deoptimization

Kathrin Eschke, Jakob Trimpert, Nikolaus Osterrieder, +1

PLoS Pathogens

Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta)

Jakob Trimpert, Julia M. Adler, Kathrin Eschke, +8

Science Advances

VaccinationVaccine SafetySars-cov-2 VariantsVaccine DevelopmentComplete Protection +12

Macrophage ACE2 is necessary for SARS-CoV-2 replication and subsequent cytokine responses that restrict continued virion release

Larisa I. Labzin, Keng Yih Chew, Kathrin Eschke, +21

Science Signaling

Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases

M. Zeeshan Chaudhry, Kathrin Eschke, Markus Hoffmann, +9

Journal of Virology

Detection of equid herpesviruses among different Arabian horse populations in Egypt

Walid Azab, Sameh Bedair, Azza Abdelgawad, +6

Veterinary Medicine and Science

Fatal Elephant Endotheliotropic Herpesvirus Infection of Two Young Asian Elephants

Selvaraj Pavulraj, Kathrin Eschke, Adriane Prahl, +7

Microorganisms

Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics

Emanuel Wyler, Julia M. Adler, Kathrin Eschke, +21

Molecular Therapy